2020
DOI: 10.1016/j.chest.2019.11.028
|View full text |Cite
|
Sign up to set email alerts
|

Predicting COPD and Lung Function Decline Among a General Population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 16 publications
(18 reference statements)
0
2
0
Order By: Relevance
“…First, our research indicates a high prevalence of OVS in OSA patients, accompanied by distinct clinical and PSG characteristics. While age and smoking are consistently identified as predictors of COPD in various studies in the general population [83][84][85], other factors such as obesity, abnormal ABG measurements not aligned with OSA severity, nocturia, and depressive symptoms may also contribute to the prediction of COPD specifically in OSA populations. Clinicians may use these readily available characteristics as predictive factors for identifying COPD in OSA.…”
Section: Discussionmentioning
confidence: 98%
“…First, our research indicates a high prevalence of OVS in OSA patients, accompanied by distinct clinical and PSG characteristics. While age and smoking are consistently identified as predictors of COPD in various studies in the general population [83][84][85], other factors such as obesity, abnormal ABG measurements not aligned with OSA severity, nocturia, and depressive symptoms may also contribute to the prediction of COPD specifically in OSA populations. Clinicians may use these readily available characteristics as predictive factors for identifying COPD in OSA.…”
Section: Discussionmentioning
confidence: 98%
“… Baseline End of intervention End of 6 months follow-up Primary outcome Exercise capacity (1-mSTS) This is a practical, reliable, valid, and responsive alternative for measuring exercise capacity, particularly where space and time are limited 22 Baseline End of intervention End of 6 months follow-up Secondary outcomes Pulmonary function tests (FEV1pred%) COPD is diagnosed through a combination of clinical symptoms and physiological measurements via pulmonary function tests. 23 Pulmonary function tests are performed by spirometry using the same machine and the same technician for all participants according to international recommendations 24 Respiratory muscle training (MIP) Respiratory or ventilatory muscle training, aims to improve inspiratory muscle strength and endurance through a series of breathing exercises. 25 Dyspnoea (mMRC) The mMRC scale measures functional breathlessness on a scale ranging from 0 to 4.…”
Section: Methodsmentioning
confidence: 99%